Stockreport

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

Fennec Pharmaceuticals Inc.  (FENC) 
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.fennecpharma.com/investor-relations
PDF ~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 [Read more]